Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review

Anthracyclines are an integral part of chemotherapy regimens used to treat a variety of childhood-onset and adult-onset cancers. However, the development of cardiac dysfunction and heart failure often compromises the clinical utility of anthracyclines. The risk of cardiac dysfunction increases with...

Descripción completa

Detalles Bibliográficos
Autor principal: Bhatia, Smita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
State-of-the-Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757557/
https://www.ncbi.nlm.nih.gov/pubmed/33364618
http://dx.doi.org/10.1016/j.jaccao.2020.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757557/
https://www.ncbi.nlm.nih.gov/pubmed/33364618
http://dx.doi.org/10.1016/j.jaccao.2020.09.006

Ejemplares similares